Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Prospectus
Announcements
2026.10.16
DATE OF BOARD MEETING
2026.09.23
POLL RESULTS OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETING
2026.09.18
2026 INTERIM REPORT
2026.09.01
NOTICE OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETING
2026.09.01
PROXY FORM
2026.09.01
Circulars - PROPOSED INCREASE TO THE LIMIT FOR PURCHASE OF WEALTH MANAGEMENT PRO...
2026.08.28
ROPOSED INCREASE TO THE LIMIT FOR PURCHASE OF WEALTH MANAGEMENT PRODUCTS AND CAS...
2026.08.28
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026
2026.08.17
DATE OF BOARD MEETING
2026.05.26
CHANGE OF EMPLOYEE REPRESENTATIVE DIRECTORS
第一页
上一页
1
2
3
4
5
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
